Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Renowned Speakers

Liane Deligdisch

Liane Deligdisch

Professor The Icahn School of Medicine at Mount Sinai USA

Diana Anderson

Diana Anderson

Professor University of Bradford UK

Dr.Khalid Shah

Dr.Khalid Shah

Director Center for Stem Cell and Translational Immunotherapy, USA USA

Dr. Dipali Sharma

Dr. Dipali Sharma

Professor Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins USA

Dr. Luigi Buonaguro

Dr. Luigi Buonaguro

Director Innovative Immunological Models Unit, National Cancer Institute - IRCCS “Pascale Italy

Dr. Mrs. Beatrice Wiafe Addai

Dr. Mrs. Beatrice Wiafe Addai

C.E.O, President Breast Care International Ghana

Massimo Cecaro

Massimo Cecaro

Editor in Chief Occupational Medicine & Health Affairs, Director of Accredited Training Centre University of Camerino Italy

Dr.Michael Retsky

Dr.Michael Retsky

Associate Professor University College London USA

Recommended Global Oncology & Cancer Webinars & Conferences

Europe & UK

Women Oncology-2023

About Conference


We welcome all the Researchers and Scholars to join us for the “6th International Conference on Women Oncology” which be held during July 27-28, 2023 at Vancouver, Canada with a theme of “One step towards improving Women’s health and combating cancer.

 

This Conference will provide a place for the interchange of the ideas and views by leading scientists, researchers. There will be masterful keynote speakers and a well-known leading scientists and experts from various places of the globe to share their ideas and speak about various aspects related to the field of oncology. Our aim is to assemble researchers, juvenile scientists, & industrialists to meet, and talk about the ideas related to it and the knowledge that’s still more to be divulged. We heartily welcome you to attend the main events of 2023 in the field of oncology.

Why to attend?

The objective of Cancer and Oncology is to bring together leading Oncologists, Radiologists, Immunologists, Clinical Researchers, Researchers, Undergraduates, Biomarker Associations and Societies, Business Entrepreneurs, Preparing Institutes, Programming creating organizations, Pharmaceutical Companies, Diagnostics Companies academic scientists and research scholars to exchange and share their experiences and research results on all aspects of Oncology and Cancer. It also provides a primary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges confronted and solutions accessible in the fields of Oncology

Our Conference will be a good platform to give the knowledge through:

  • Innovative talks by the experts of the global scientific community
  • Remarkable Awards and Global Recognition to Worthy Researchers
  • Global Networking with 50+ Countries across the globe
  • Novel Techniques to Benefit Your Research
  • Global Business and Networking Opportunities
  • Exquisite Platform for showcasing the products and International Sponsorship

Target Audience

  • Academicians including Professors.
  • PhD Scholars
  • Students carrying out laboratory and field studies
  • Noble laureates in Health Care and Medicine
  • Pharmacists
  • Pathologists
  • Forensic Professionals
  • Cancer Researchers
  • Oncologists
  • Radiation Oncologists
  • Surgeons
  • Nurses
  • Physicians
  • Medical Students

 

Tracks/Sessions

Track 01: Cancer Development

Simply put, cancer is that the results of unregulated biological process. Cancer cells divide once they do not appear to be presupposed to, do not stop dividing once they square measure presupposed to and do not die once they have to. Among the worst cases, the cancer cells leave the earth among that they arose and travel totally different elements of the body. They changes square measure typically the results of changes to the deoxyribonucleic acid (mutations) among the cells. As a results of their square measure many alternative things that square measure capable of inflicting mutation, there square measure Associate in nursing equally sizable amount of causes of cancer, they gain new capabilities, similar to the flexibleness to unleash growth factors and method enzymes. The cells still divide, impacting shut ancient cells, typically reducing the operate of the affected organ.

Track 02: Oncology Research

Oncology is that the branch of medication that researches identifies and treats cancer. It's the procedure of treating cancer by mistreatment substances made of living organisms which might be obtainable naturally within the body or created in laboratory. They stimulate or suppress the system to assist the body fight against cancer or the other infectious diseases. This includes pathology of cancer, cancer medical specialty, acquainted cancer syndromes, differing kinds and principles of medicine, medicine nursing and care, medicine analysis and principles of multidisciplinary management.

Track 03: Cancer Science

World Oncology involves understanding the functioning and expression of oncogenes. Gene mutation or irregular functioning of signal transduction pathways results in uncontrolled cell division by blocking the pathways for programmed cell death or apoptosis. Novel therapies for cancer involve targeting these pathways for controlling tumour growth. Monoclonal antibodies, cloned genetic sequences are some of the newest approaches adopted in the mitigation of cancer.

Track 04: Cancer Treatment

Cancer treatments can cause aspect effects. Aspect affects square measure issues that occur once treatment affects healthy tissues or organs. Speak up regarding any aspect affects you have got, or changes you notice, therefore your health care team will treat or assist you to scale back these aspect effects. Differing types of treatments embody surgery, targeted medical care, secretion medical care, vegetative cell transplant, exactness medication and their several aspect effects.

                                                                                   Track 05: Cardio Oncology

Cardio-oncology additionally referred to as vessel medical specialty is Associate in Nursing integrative field of medication, wont to study the molecular and clinical alterations in circulatory system throughout the treatment of cancer particularly chemo and targeted medical care. Medical specialty could be a branch of medication that involves the bar, diagnosis, and treatment of cancer and Tumours. The high risk of cancer will increase with the rise in age.

Track 06: Cancer Risk Factors

It is sometimes impractical to understand precisely why one person develops cancer and another does not. However analysis has shown that bound risk factors could increase human possibilities of developing cancer. These are generally referred to as protecting risk factors or simply protecting factors. Limiting your exposure to avertable risk factors could lower your risk of developing bound cancers. It includes age, tobacco, cancer inflicting substances, obesity, alcohol, infectious agents.

Track 07: Breast Cancer, Cancer Therapies And Breast Cancer Treatment

An infection that designs in the cells of the breast. Breast Cancer can occur in Women and inconsistently in men. Signs of breast illness recall a bunch for the breast, underhanded delivery from the areola and changes in the shape or surface of the areola. Its treatment depends upon the period of harm. It may contain chemotherapy, radiation, synthetic therapy and operation.

  • Chemotherapy
  • Malignancy
  • Radiation Therapy

This part reveals to you the medicines that region unit the norm of post of beginning phase and locally progressed carcinoma. "Standard of care" proposes that the best medicines distinguished. once making treatment mastermind choices, patient's region unit propelled to ponder clinical preliminaries as partner plausibility. A test may be an examination concentrate on that tests a substitution way to deal with treatment. Specialists wish to be told whether the new treatment is protected, compelling, and apparently over the standard treatment. Clinical preliminaries will check a substitution drug and the way typically it should lean, a substitution mix of common medicines, or new portions of conventional prescription or elective medicines.

  • Partial breast irradiation
  • Routine cancer genotyping
  • Proton beam radiation

Not all young ladies with carcinoma can need chemo, but there are numerous things during which chemo could likewise be suggested: After medical procedure (adjuvant chemotherapy): Adjuvant chemo is utilized to do to kill any malignant growth cells that may are abandoned or have unfurl anyway can't be seen, even on imaging tests. On the off chance that these cells could develop, they may kind new growths in elective spots inside the body. Adjuvant chemo will bring down the shot at carcinoma returning. Prior to medical procedure (neoadjuvant chemotherapy): Neoadjuvant chemo will be acclimated endeavor to contract the neoplasm along these lines it will be taken out with less top to bottom a medical procedure. because of this, neoadjuvant chemo is typically acclimated treat malignant growths that are too immense to be in any way taken out by a medical procedure at the hour of ID (called locally progressed diseases). Likewise

  • Breast ultrasound
  • Breast Magnetic Resonance Imaging
  • Mammography

Track 08: Oncology Nursing

medical specialty nurse could be a specialised nurse World Health Organization cares for cancer patients. These nurses need advanced certifications and clinical experiences in medical specialty additional than the everyday baccalaureate nursing program provides. medical specialty medical aid will outlined as meeting the varied wants of medical specialty patients throughout the time of their sickness together with applicable screenings and different preventative practices, symptom management, care to retain the maximum amount traditional functioning as potential, and corroboratory measures upon finish of life.

Track 09: Cancer Vaccines

Cancer vaccines stimulate the immune system’s capability to protect the body against the infectious agents that may cause disease. Cancer vaccine is also known as biological response modifiers. There are two types of cancer vaccine: Preventive vaccine and treatment vaccine. The Preventive vaccine is used to stop the development of the Cancer cell and treatment vaccines are used to treat the existing cancer by natural immune system to fight against the cancer.

Oncolytic Virus is a virus that infects and breakdown Cancer cells but not normal cells. Oncolytic virus therapy may make it easier to kill tumor cells with chemotherapy and radiation therapy. It is a type of targeted therapy. Also called oncolytic virotherapy, viral therapy, and virotherapy.

  • Cancer Cell Mechanisms
  • Cancer Clinical trials
  • Cancer Epidemiology
  • Cancer Biostatistics
  • Medical Oncology
  • Interpretive Oncology

Track 10: Radiation Oncology

The use of radiation to treat cancer is outlined as Radiation medicine. X-rays, gamma rays, or electrons area unit a number of the radiations won’t to treat the Radiation medicine. Therefore Oncologists uses radiation to treat a number of the benign diseases and benign tumours. Radiation medicine is one among the first specialities of surgical and medical medicine, that area unit concerned within the treatment of cancer. The sector of radiation medicine provides the combination of irradiation into multimodal treatment approaches. Radiation medicine focuses on all aspects of analysis that impacts on the treatment of cancer victimisation radiation

Track 11: Nanotechnology In Cancer Treatment

The Nanoparticles or Nanotechnology in Cancer Treatment deals with destruction, detection, and elimination of the cancer cells with minimal harm to the healthy tissue present near. Nanoparticles are inoculated directly into the cancer cells and can destroy the proliferation of the Cancer cell present inside. Nanoparticle plays major role in drug delivery to overcome the limits of conventional treatment methods.

  • Delivering life through chemotherapy
  • Nano therapy for Cancer
  • Augmenting radiotherapy

Track 12: Cancer Stem Cells

Cancer stem cells (CSCs) measure cancer cells that possess characteristics related to traditional stem cells, specifically the flexibility to provide rise to all or any cell varieties found in an exceedingly explicit cancer sample. CSCs square measure so tumorigenic (tumour-forming), maybe in distinction to alternative non-tumorigenic cancer cells. Development of specific therapies targeted at CSCs holds hope for improvement of survival and quality of your time amount of cancer patients, considerably for patients with biological process wellness.

Track 13: Precision Medicine And Immuno-Oncology

Precision medicine or personalized medicine is an approach to individual care for selecting treatment that are helpful to the patients based on a genetic understanding of their disease. Depending upon the type of cancer, its size and proliferation, combination of Treatment surgery, Chemotherapy, Radiation therapy and Immunotherapy may vary. But in precision medicine, information about genetic changes in the tumor can be helping to decide the Treatment.

Cancer Immunology is concerned with Immune system in progression and development of Cancer. The most well-known application is Cancer Immunotherapy where the immune system is used to treat cancer.

  • Novel concepts in Bi-specific Antibodies Engineering
  • Pre-clinical and Translational Immuno-Oncology Developments
  • Personalized Immunotherapy, Combination Immunotherapy and Viral Therapies

Track 14: Types Of Cancers

Cancer may be a common condition. It's calculable that one in 2 folks can develop some kind of cancer throughout their lifespan. Being awake to general signs and symptoms connected to the condition will facilitate in early detection. This is often vital as a result of the sooner a cancer is detected, the higher the possibilities of thriving treatment. Signs and symptoms of a number of the cancers like female internal reproductive organ cancer, cervix cancer, thyroid cancer, carcinoma, urinary organ cancer etc...

Track 15: Cancer Health Disparities

Here has been substantial progress in cancer treatment, screening, diagnosis, and prevention over the past several decades, addressing cancer health disparities—such as higher cancer death rates, less frequent use of proven screening tests, and higher rates of advanced cancer diagnoses—in certain populations is an area in which progress has not kept pace.

These disparities are frequently seen in people from low-socioeconomic groups, certain racial/ethnic populations, and those who live in geographically isolated areas.

Documented cancer health disparities include: A higher incidence of a particularly aggressive form of breast cancer (the triple-negative subtype) among African American women than women of other racial/ethnic groups

substantially higher rates of prostate cancer incidence and death among African American men than men of other racial/ethnic groups

higher rates of kidney cancer among American Indian and Alaska Natives than other racial/ethnic groups. Higher rates of liver cancer among Asian and Pacific Islanders than other racial/ethnic groups

higher rates of cervical cancer incidence and death among Hispanic and African American women than women of other racial/ethnic groups. Many of the same population groups that experience cancer health disparities are also significantly underrepresented in cancer clinical trials.

There has been some recent evidence of progress against cancer health disparities, including reductions in lung and prostate cancer deaths among African American men over the past decade. But researchers and public health officials agree that progress has come too slowly, and the cost of disparities—in terms of premature deaths, lost productivity, and the impact on communities—remains substantial and must be addressed. Cancer disparities and equity research is needed to understand why some groups of people may be more or less likely to develop cancer, experience cancer-related health problems, or die from cancer than other groups of people.

Track 16: Organ Specific Cancer

Cancer may be a condition wherever cells in a very specific a part of the body grow and reproduce infinitely. The willcerous cells can enter and destroy encompassing healthy tissues together with organs. There are differing types of cancer supported location of cancer within the body. A number of the organ cancers such as carcinoma and epithelium, carcinoma, body part cancer, cancer of oesophagus , Cervical cancer ,Endometrial cancer, Head and Neck cancers and cancers of unknown primary.

Track 17: Pulmonary Oncology

Our cancer doctors establish tumours, blockages or internal haemorrhage and use advanced carcinoma treatments to cut back or eliminate symptoms. Treatment-related facet effects: Some carcinoma treatments, like therapy, might cause scarring within the lungs. Whereas we tend to attempt to scale back these facet effects, aggressive carcinoma treatment might cause ineluctable complications. We tend to use sure interventional pulmonology procedures to treat your symptoms and to differentiate between a facet result of treatment and therefore the progression of cancer.

Track 18: Cancer Preventive Vaccines: Oncolytic Therapy & Others

Cancer vaccines stimulate the immune system’s capability to protect the body against the infectious agents that may cause disease. Cancer vaccine is also known as biological response modifiers. There are two types of cancer vaccine: Preventive vaccine and treatment vaccine. The Preventive vaccine is used to stop the development of the Cancer cell and treatment vaccines are used to treat the existing cancer by natural immune system to fight against the cancer.

Oncolytic Virus is a virus that infects and breakdown Cancer cells but not normal cells. Oncolytic virus therapy may make it easier to kill tumor cells with chemotherapy and radiation therapy. It is a type of targeted therapy. Also called oncolytic virotherapy, viral therapy, and virotherapy.

  • Cancer Cell Mechanisms
  • Cancer Clinical trials
  • Cancer Epidemiology
  • Cancer Biostatistics
  • Medical Oncology
  • Interpretive Oncology

Track 19: Cancer Epidemiology, Screening, Diagnosis & Prognosis

The Epidemiology of Cancer is the investigation of the components influencing Cancer, an approach to finish up potential inclinations and causes. The investigation of Cancer Epidemiology rehearses Epidemiological Methods to find the reason for Cancer and to perceive and create upgraded medicines. This degree of concentrate must adapt to challenges of lead time predisposition and length time inclination. Lead time inclination is the hypothesis that essential conclusion may falsely expand the endurance measurements of a Cancer, without really improving the characteristic history of the illness. Length predisposition is the idea that delicate developing, progressively torpid Tumors are bound to be perceived by Screening Tests, yet upgrades in diagnosing more instances of lethargic Cancer may not convert into better patient results after the execution of Screening Programs.

Most Cancers are initially known either in light of the presence of signs or indications or through Screening. Neither of these prompts a Definitive Diagnosis, which involves the assessment of a tissue test by a pathologist. Individuals with suspected Cancer are seen with medicinal tests. These for the most part incorporate Blood Tests, CT Scans, X-beams and Endoscopy.

Screenings can discover introductory Cancer, when it's generally reparable. Disease Screening means to recognize Cancer before manifestations show up. This may incorporate blood tests, pee tests, different tests, or Medical Imaging.

  • Microfluidic device for cancer screening
  • Cancer Staging
  • Early detection and diagnosis of Cancer
  • Circulating tumor cells (CTCs) towards cancer Diagnosis
  • Cohort studies and Cancer Survival analysis

Track 20: Phases And Types Of Clinical Trails

Different types of clinical trials performed on cancer patients supported their sort of cancer. Clinical trials are going to be differentiated supported sort of cancer. Part l trials are the ultimate step during a long method that begins with analysis during a laboratory. Before any new treatment is employed with folks in clinical trials, researchers work for several years to know its effects on cancer cells within the laboratory and in animals. They additionally try and puzzle out the aspect effects it should cause. Clinical trials sometimes include treatment trails, preventive trails, screening trails, palliative care trails.

Track 21: Cancer Biology

The science that deals with cancer cells area unit called Cancer Biology. The most aim of cancer biology is to grasp the abrupt modification in cells and the way it's developed and varied from traditional cells to cancer cells. These manners of analysis in cancer biology have arranged a path to hindrance, identification and treatment. Tumours are unit thought-about by genomic and epigenetic uncertainty that modifies the needs of assorted altered particles and systems during a solo cell still as varied the communications with the native scenario. Cancer systems biology attitudes, therefore, area unit grounded on the custom of machine and precise systems to translate the complication in growth creation still as cancer no uniformity.

Track 22: Circulating Tumor Cell (CTC)

Circulating Tumor Cell are the cells that are shed into the lymphatic or vasculature stream from a tumor and remain loose in circulation, cluster together as they travel or lodge themselves in new tissues. The detection of Circulating tumor cell has important Diagnostic and Therapeutic implication then their number can be very small and cells are not certainly identified.

  • Methods of CTC detection
  • CTC number as a surrogate response and prognostic biomarker
  • CTC chip technology and EGFR mutation analysis
  • Application of CTC technologies to clinical testing

Track 23: Gynecologic Oncology

Gynaecologic medical specialty could be a specialised field of medication that focuses on cancers of the feminine system, as well as gonad cancer, female internal reproductive organ cancer, canal cancer, cervical cancer, and vulvar cancer. As specialists, they need intensive coaching within the diagnosing and treatment of those cancers.

Track 24: Neonatal And Pediatric Oncology

Neonatal medical specialty may be a sub specialty of medical specialty that deals with the hindrance, diagnosis, and treatment of cancer in babies. New born cancer is rare and contains a heterogeneous cluster of neoplasms with substantial microscopic anatomy diversity. The causes of infant cancer are unclear; however genetic factors in all probability have a key role.

Track 25: Cancer Biomarkers

Cancer biomarkers talk to a molecule or substance secreted by the body in response to presence of tumour cells within the body. Biomarkers are wont to establish early stage cancer, or to diagnose the wellness condition of patient. It may also be wont to outline the prophetic treatment or monitor the treatment method given to the patients.

Track 26: Genetic Mutations Of Cancer

Cancers are caused by a change in, or damage to one or more genes. Mutations can stop genes from working properly. Gene mutations happen when we are born with a mutated gene that is either inherited from a parent or that develops in an embryo and also when we are exposed to something around us that damages our genes, like cigarette smoke. It takes more than one gene mutation for a cell to become cancerous .But there are also cancers where we don’t know which gene mutations cause them.

Track 27: Veterinary Oncology

Many cancers in veterinary oncology are detected only when they are very advanced. Part of this is because our patients cannot tell us when something just isn't right, but also because they will carry on appearing relatively normal to the client but just ‘slowing down’. Many cancers are occult and it may be some time before an obvious abnormality becomes apparent. Offering good diagnostic evaluations early will improve prompt detection of cancer and the opportunity to treat patients early; this in itself will improve survival times for many patients.

Track 28: Cancer Drugs

The implementation of new drug treatments has improved the prognosis for advanced cancer of the cervix, uterus, and ovary. Platinum analogs are the most effective drugs in the treatment of ovarian cancer. Fertility drugs (FD) are spreading worldwide fast and therefore many studies have reviewed the possible association between the use of these drugs and cancer. Since the drugs used for ovulation induction during in-vitro fertilization (IVF) like hCG, hMG, rFSH increase the levels of gonadal hormones, concerns have grown regarding the risk of developing cancer in breast, ovary, endometrium, and other target organs. If the treatment plan involves chemotherapy you may experience physical, emotional, and/or psychological side effects related to this treatment. The side effects of ovarian cancer treatment depend on the type of treatment and may be different for each woman.

  • New Drugs in Gynaecologic Cancer
  • Fertility Drugs and Gynaecologic Cancer
  • Side Effects of Drugs
  • Pharmaceutical management

Market Analysis

Oncology Market Size exceeded USD 270.5 billion in 2021 and is anticipated to grow at 10.2% CAGR between 2022 and 2028. Rising alcohol and tobacco consumption have led to the rise in global oncology burden. Also, as the industry players lay a strong emphasis on developing novel drug candidates targeting different types of cancers, a steady growth is poised in the market during the forecast period.

 

Women Oncology-2023


The COVID-19 pandemic has impacted every aspect of oncology care and research, as several countries across the globe have classified screening and oncology care services as a relatively low-priority services. For instance, the government of Scotland temporarily suspended screening programs for cervical, bowel and breast cancers in light of increasing cases of COVID-19 pandemic.

 

Moreover, several local- and national-level restrictions implemented by public and private authorities on the movement of people and goods is noted to significantly disrupt the pharmaceutical products and ingredients supply chain, thereby hampering the industry growth. Additionally, temporary closure of various academic institutes and challenges in providing post-sales services owing to the pandemic, resulted in the reduced supply of oncology product to end users, thereby hindering with the market expansion.
Oncology Market Report Coverage

 

Technological advancements and automation have enhanced the accuracy levels of cancer tests and also made them user friendly, thereby fostering the industry expansion. For instance, liquid-based cytology (LBC) tests were developed to overcome difficulties in conventional pap test for cervical cancer screening. Liquid based cytology (LBC) test reduces specimen inadequacy by around 80%, thus allowing further applications in chlamydia, HPV and gonorrhoea testing.
 

Side effects associated with the cancer treatment may potentially restrain the oncology market value

 

Side effects associated with oncology treatment such as chemotherapy can potentially hinder the growth of global industry. Patients undergoing chemotherapy may suffer from long-term damage to the heart, lungs, kidneys, or reproductive organs. This can occur after the treatment by damaging the healthy cells, thus limiting the industry progression. Moreover, certain types of chemotherapy drugs may cause delayed side effects. Few of the common side effects include hair loss, fatigue, anaemia, infections and easy bruising & bleeding among others, thereby hampering the overall market demand.
 

Technological advancements in cancer diagnostics to further accelerate adoption rate of cancer diagnostic tools

 

The cancer diagnostic segment dominated more than 46.6% of the market share in 2021 led by the rising incidence of cancer coupled with technological advancements. The development of an intelligent surgical knife fulfils the growing demand for minimal invasive technologies. Furthermore, detecting cancer merely with physical exams or biomarker tests is noted to be an onerous task while imaging test is must for conformation.
 

Increasing prevalence of breast cancer will influence the segment growth

 

Women Oncology-2023


Breast cancer segment valued at USD 54.06 billion in 2021 due to the rising obesity, hormonal imbalance, age-related risks and replacement therapy in women, the prevalence of breast cancer increases. Additionally, various government initiatives such as BreastScreen Aotearoa in New Zealand providing free tests to women will further augment the industry value over the forthcoming years.

 

Availability of various technologically advanced devices and growing hospital admission to positively impact the segment expansion

 

Hospital segment is expected to register 10.4% growth rate through 2028. High acceptance rates for technologically advanced biopsy and other devices utilized in diagnosis of cancer will increase the number of diagnosis carried out in hospitals, thereby stimulating the industry demand. In addition, the increasing presence of electrosurgical procedures and related minimally invasive surgeries has increased the admissions and adoption of oncology treatment in hospital setting, thereby enhancing the segment progression.
 

Rising prevalence of cancer disease along with increasing geriatric population in the North America region

 

Women Oncology-2023


North America oncology market accounted for 45.8% of revenue share in 2021 driven by the growing geriatric population along with rising incidence of cancer in the region. Furthermore, technological advancement in cancer diagnostic techniques and treatment, favourable R&D activities by industry participants are the few other factors that will favour the regional growth.

 

Growth strategies of market players are focused on increasing the customer base

 

Few of the notable companies operating in the market are GE Healthcare, Janssen Diagnostics, LLC (Johnson & Johnson), F. Hoffmann-La Roche, Pfizer, Bayer AG, Merck, Abbott, Thermo Fischer Scientific. These industry leaders implemented various strategies such as mergers and acquisitions, collaborations, new product launch, etc. in order to capture high revenue share in the market.

The global oncology market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2017 to 2028, for the following segments:

 

Market, By Cancer Diagnostics & Treatment

  • Cancer diagnostics

    • Tumor Biomarkers Test

    • Imaging

    • Biopsy

    • Liquid Biopsy

    • Immunohistochemistry

    • In Situ Hybridization

  • Cancer treatment

    • Chemotherapy

    • Targeted therapy

    • Immunotherapy

    • Hormonal therapy

    • Others

Market, By Cancer Type

  • Lung cancer

  • Prostate cancer

  • Colon & rectal cancer

  • Gastric cancer

  • Esophageal cancer

  • Liver cancer

  • Breast cancer

  • Others

Market, By End-use

  • Hospitals

  • Diagnostic laboratories

  • Diagnostic imaging centers

  • Academia

  • Specialty clinics

  • Others

The above information is provided for the following regions and countries:

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

  • Asia Pacific

    • China

    • India

    • Japan

    • Australia

  • Latin America

    • Brazil

    • Mexico

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

Benefits of Participation

  • As an add on advantage the Speaker & Abstract pages created in Google on your profile under your name would get worldwide visibility
  • Our robust online publicity attracts 20000+ users and 60000+ views to our Library of Abstracts which brings worldwide exposure to the researchers and speakers participate in our conferences
  • All the conference participants can earn up to 16-18 CME Credits by participating at our Women Oncology - 2023 Conference scheduled at Montreal, Canada.
  • To attain professional development we offer our participants a chance to earn up to 21 CPD Credits authorized by CPD Standards Office, UK by participating at our Women Oncology - 2023.
  •  All the conference participants will be awarded with IOCM Certification.
  •  All the conference participants will have an unique opportunity to participate at One on One Meeting with Eminent Speakers
  •  A Unique opportunity to hear what the global researchers are talking about at our Keynote sessions by world’s most eminent researchers in the field of  Women Oncology - 2023
  • Top Industries Representation of Industrial Leaders, where you get a great opportunity to meet and discuss with the Industrial Leaders in person
  • Thought provoking Symposia’s
  •  Workshops on Carrier Development
  •  Preconference workshops in all major countries
  •  Nominations for Best Poster Award
  •  Outstanding Young Researcher Award
  •  Group Registration benefits

Benefits of Participation | Speaker

  • Explore the best in Cutting edge Research
  • Worldwide acknowledgment of Researcher’s profile
  • Obtain professional development credits
  • Your presence and talk will be recorded and hosted on YouTube and Video which in turn will gain potential value to your research profile.
  • Make Lasting connections at Networking and Social Events
  • We provide unique convergence of Networking, Learning and Fun into a single package
  • An opportunity to give One page advertisement in abstract book and flyers distribution which eventually gets 1 Million views and add great value to your research profile
  • Learn beyond your field of interest, a change to know more about the new topics and research apart from your core subject

Benefit of Participation | Sponsor

  • Worlds No1 Platform to show case  Women Oncology – 2023 Products
  • Exposure to the international atmosphere will increase the odds of getting new business
  • Opportunity to showcase the new technology, new products of your company, and/or the service your industry to a broad international audience
  • Attain with an exceptional format in showcasing the products and services and to gain the potential clients for the future business prospects
  • Our Women Oncology – 2023 Conference in the One and only location to reach the top customers
  • Make new connections and fostering potential partnerships
  • Increase your business by lead generation through our conference participants.
  • Build a successful business takes a lot of time, effort and drive, so it’s always good to have a network of colleagues and associates to draw energy from people who share a similar drive and objective.
  • Flip side of learning new things is relearning classic techniques. Women Oncology - 2023conferences create opportunities for greater focus and reflection that could help you take your business to the next level.
  • Benchmarking key strategies for business and moving it forward
  • Get answers to your business questions and challenges from credible individuals at our conference
  • Exposure and Networking Opportunity with the various top decision makers of the respective organizations, will eventually grow your business in Global market
  • Get to know more about your competitors are first-hand, learn more about their businesses, and discover their strengths and weaknesses, all of which can add to your business’s competitive edge.
  • Encounter new vendors and suppliers for your business
  • Real Benefits in New business - Many Organizations make deals and sign contracts at our Women Oncology - 2023.
  • We offer you the Website visibility to more than 35K visitors in less than 6 months
  • Promotional logo of your organisation at our conference banner, website and other proceedings, branding and marketing material
  • Hosting session slots, poster awards, recognition in opening ceremony and complimentary registrations, exhibition/workshop booth, low-budget options.

Benefit of Association for Collaborators

  • No one in the world have this huge visitors towards Breast pathology 2023, these is the best platform to show case your society.

    Create long-lasting relationships with the peers

  • Promotional content and Logo of your Association at our conference banner, website and other proceedings, branding and marketing material will increase your subscribers/Members number by 20 %.
  • Our Website visibility to your Organization page can give a great impact for your association in the Global Market.
  • Your representatives can network with key conference delegates to update their knowledge and understanding of your organization and services.
  •  Details will be added to the conference press release where the details will be shared to < 100000 outlets
  •  Details will be incorporated in all conference promotional materials which will be distributed to Hospitals, Universities, Society and Researchers

Benefits of Participation | Delegate

  • Helps to meet Experts & Influencers Face to Face.
  • Opportunities to meet researchers and experts of same field and share new ideas
  • Can help to know New Tips & Tactics
  • Professional Development – Elevate your knowledge and Skills
  • Conference attendance inspires, rejuvenates, and energizes delegates
  • Your participation at our conference will be helpful for a new approach and ideology that can be utilized for the extending the outcome of Companies or Industries.
  • Enjoy the alluring city environment where the conference is being held.
  • Raise your profile by being well-known

Visa Application Process

Visa Application Documents You should only apply for business visas to attend and attend conferences. Contact your nearest Vancouver, Canada Travel Agency/Visa Information Center/Embassy for the correct application form.

All visas for the visit to Vancouver, Canada are processed by the respective embassy authorities in the correct way only after the presentation of the corresponding documents.

If no documents are provided or if the guidelines are not followed, the competent authorities hold the right to reject/cancel the visas.

The minimum documents that may be required when applying for the visa from / Vancouver, Canada include:

  • Official Letter of Invitation
  • Letter of Acceptance/Approval for abstracts (if you are a speaker)
  • Proof of payment receipt for registration
  • Hotel Booking Confirmation Letter for accommodation issued on conference letterhead

Note: For the Letter of Invitation and Accommodation Confirmation, payment of registration and accommodation fees is a prerequisite. Please contact us for more information

To Collaborate Scientific Professionals around the World

Conference Date July 27-28, 2023

Speaker Opportunity

Supported By

Journal of Integrative Oncology

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by


Media partners & Collaborators & Sponsors

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner